financetom
Business
financetom
/
Business
/
AST SpaceMobile to Provide Cellular Service to Verizon Customers From 2026
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AST SpaceMobile to Provide Cellular Service to Verizon Customers From 2026
Oct 8, 2025 8:00 AM

10:30 AM EDT, 10/08/2025 (MT Newswires) -- AST SpaceMobile ( ASTS ) said Wednesday that it agreed to provide its direct-to-cellular service to customers of telecommunications giant Verizon Communications ( VZ ) from next year.

The companies aim to use Verizon's 850 megahertz cellular spectrum and AST's space-based cellular network to enable customers to stay connected "when needed," AST said. Financial terms of the deal weren't disclosed.

"Through our definitive commercial agreement with Verizon, we are working to deliver space-based cellular broadband coverage from space across the continental United States," AST Chief Executive Abel Avellan said in the Wednesday statement. "The agreement will extend the scope of Verizon's 850 MHz premium low-band spectrum into areas of the US that would benefit from the ubiquitous reach of space-based broadband technology."

The agreement expands a partnership the two companies announced in May 2024, when AST secured a $100 million commitment to provide its services to Verizon customers.

Shares of AST climbed 9.9% in Wednesday trade, and have surged 289% so far this year. Verizon's stock edged down 0.6%.

"We are not just filling in the map; we are creating a new paradigm of connectivity that will unlock the full potential of the digital age," Verizo's senior vice president of technology and product development, Srini Kalapala, said.

Earlier in the week, Verizon named former PayPal (PYPL) CEO Dan Schulman as its new chief executive, succeeding Hans Vestberg, who also stepped down as chairman. Mark Bertolini become the company's new chairman.

Verizon reiterated its full-year guidance for 2025, and delayed the release of its third-quarter results to Oct. 29 from Oct. 21.

Price: 86.29, Change: +11.54, Percent Change: +15.44

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved